| Financial Year |
March 31 2023 |
| Monetary Funds |
1,243,449,352.77 |
| Held-for-trading Financial Assets |
555,615.49 |
| Notes Receivable |
22,904,958.42 |
| Accounts Receivable |
1,039,697,562.80 |
| Advances to Suppliers |
56,696,647.66 |
| Other Receivables |
160,553,711.57 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
439,456,388.10 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
22,903,801.40 |
| Total Current Assets |
3,092,900,559.15 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
159,382,681.71 |
| Investment Properties |
356,077,692.20 |
| Fixed Assetes |
1,195,272,104.96 |
| Under-construction Projects |
137,872,318.23 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
439,718,576.39 |
| R&D expenses |
-- |
| Goodwill |
90,398,260.88 |
| Long-Term Deferred and Prepaid Expenses |
36,397,449.29 |
| Deferred Income Tax Assets |
60,117,694.57 |
| Other Non-Current Assets |
50,942,390.78 |
| Sub-Total of Non-Current Assets |
2,651,380,045.25 |
| Total Assets |
5,744,280,604.40 |
| Short-Term Loans |
611,315,240.15 |
| Trading Financial liabilities |
-- |
| Notes Payable |
63,200.00 |
| Accounts Payable |
624,627,166.29 |
| Accounts Received In Advance |
4,371,391.20 |
| Employee Compensation Payable |
17,650,905.35 |
| Taxes Payable |
54,949,332.44 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
140,995,836.14 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
21,194,240.48 |
| Other Current Liabilities |
16,439,180.01 |
| Sub-Total of Current Liabilities |
1,627,899,865.85 |
| Long-term Loans |
121,220,791.27 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
2,709,053.73 |
| Deferred Income Tax Liabilities |
5,095,657.62 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
984,709,244.67 |
| Total Liabilities |
2,612,609,110.52 |
| Paid-In Capital(Or Share Stock) |
326,272,755.00 |
| Capital Surplus |
1,286,304,316.64 |
| Surplus Reserve |
114,731,597.48 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
1,046,523,300.38 |
| Minority Stockholder's Interest |
358,999,479.48 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
2,772,672,014.40 |
| Owner's Equity（Stockholder's Equity） |
3,131,671,493.88 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
5,744,280,604.40 |
